非典型肾上腺肿块的临床与影像学特征——一项多中心回顾性研究
这项多中心回顾性研究纳入217例患者共224个非典型肾上腺肿块(直径10-39 mm、平扫CT衰减>10 HU),中位随访显示肿块中位生长速率0.3 mm/年,31.7%接受病理评估,肾上腺腺瘤(17%)与肾上腺皮质癌(11.2%)最常见;预测恶性的最佳生长速率截断值为2.68 mm/年(AUC 0.939;敏感度87.5%,特异度88.8%)。结论认为非典型肾上腺肿块具有显著恶性潜能,未手术者需长期随访,而对比剂洗脱率不能可靠预测恶性潜能。
要点
- 非典型肾上腺肿块中位生长速率0.3 mm/年,但肾上腺皮质癌可达12.9 mm/年。
- 预测恶性的最佳生长速率截断值2.68 mm/年,AUC 0.939,敏感度87.5%,特异度88.8%。
- 7例肾上腺皮质癌中5例(71.4%)绝对对比剂洗脱率>60%,提示洗脱率不能可靠预测恶性。
核心结论
- 非典型肾上腺肿块具有显著恶性潜能,未行手术者需长期随访;对比剂洗脱率不能可靠预测其恶性潜能。
研究设计与样本
- 多中心回顾性研究,纳入年龄≥18岁、首次影像学检查直径10-39 mm且CT平扫衰减>10 HU的非典型肾上腺肿块患者,排除肾上腺转移瘤、嗜铬细胞瘤、肉瘤、淋巴瘤、浸润性病变、肾上腺出血及有肾上腺肿瘤遗传易感性者。
- 共纳入217例患者、224个肾上腺肿块,其中女性61.3%,中位年龄58岁(IQR 49-65岁)。
主要发现
- 肿块中位大小20.5 mm(IQR 15-27 mm),中位平扫衰减23.5 HU(IQR 17-30 HU),中位生长速率0.3 mm/年(IQR 0-1.8 mm/年)。
- 71个肿块(31.7%)接受病理评估,最常见的诊断为肾上腺腺瘤(n=38;17%)和肾上腺皮质癌(n=25;11.2%)。
- 肾上腺腺瘤生长速率0.3 mm/年(IQR 0-2.3 mm/年),肾上腺皮质癌生长速率12.9 mm/年(IQR 3.5-22 mm/年)。
- 7例肾上腺皮质癌中5例(71.4%)绝对对比剂洗脱率>60%。
关键数值与推荐
- 预测恶性的最佳生长速率截断值为2.68 mm/年(AUC 0.939;敏感度87.5%,特异度88.8%)。
临床怎么用
- 原文结论指出非典型肾上腺肿块具有显著恶性潜能,未行手术者需长期随访;原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The natural history and malignant potential of cases classified as atypical adrenal masses (AAMs) are unknown. OBJECTIVE: To describe the radiological characteristics and clinical outcomes of AAMs. DESIGN AND PARTICIPANTS: A multicenter retrospective study. Patients ≥18 years old with AAMs [diameter of 10-39 mm on first imaging study and pre-contrast attenuation of >10 Hounsfield units (HU) on computed tomography] were studied. We excluded adrenal metastasis, pheochromocytoma, sarcoma, lymphoma, infiltrative lesions, and adrenal hemorrhage, as well as patients with genetic predisposition to adrenal neoplasms. Data are presented as percentages and median values with interquartile ranges (IQRs). RESULTS: We included 217 patients with 224 adrenal masses (61.3% women); the median age was 58 years (IQR 49-65 years). The median size was 20.5 mm (IQR 15-27 mm), with a median precontrast attenuation of 23.5 HU (IQR 17-30 HU). The median AAM growth rate was 0.3 mm/year (IQR 0-1.8 mm/year). Seventy-one masses (31.7%) underwent pathological evaluation. Adrenal adenoma (n = 38; 17%) and adrenocortical carcinoma (ACC) (n = 25; 11.2%) were the 2 most common diagnoses. For the adenomas, the growth rate was 0.3 mm/year (IQR 0-2.3 mm/year) and for ACCs, the growth rate was 12.9 mm/year (IQR 3.5-22 mm/year). The absolute contrast washout was >60% in 5 out of 7 (71.4%) ACC cases. The best growth rate cutoff for predicting malignancy was 2.68 mm/year (area under the curve 0.939; sensitivity 87.5%, specificity 88.8%). CONCLUSION: AAMs carry significant malignant potential, and long-term follow-up is warranted when surgery is not pursued. Contrast washout is not reliable in predicting malignant potential of AAMs.
引用
- Balderrama-Brondani V, Al-Ward R, Kiseljak-Vassiliades K, et al. Clinical and Radiological Features of Atypical Adrenal Masses-A Multicenter Retrospective Study. J Clin Endocrinol Metab. 2025. PMID: 39503236. doi:10.1210/clinem/dgae781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。